Product Images Lagevrio
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Lagevrio NDC 0006-5055 by Merck Sharp & Dohme Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
lagevrio 01
lagevrio 02
This text appears to be a table containing various parameters and their values related to a clinical trial for a drug called LAGEVRIO. The parameters listed in the table include the time from symptom onset to randomization, age, sex, obesity, diabetes mellitus, baseline COVID severity, baseline clades, baseline antibody status, and a comparison of the number of events and subjects between LAGEVRIO and placebo. The table also presents the risk differences in percentage values along with their 95% confidence intervals.*
lagevrio 03
Lagevrio is a medication available in capsule form containing 200mg molnupiravir for use under Emergency Use Authorization. It is recommended to store the capsules between 20°C to 25°C (68°F to 77°F). The medication is only available with a prescription and should be dispensed in its original container. The box contains 40 capsules. The package provides a QR code or a URL to access the FDA-authorized Fact Sheet for dosage and administration. The text also includes details about the GTIN code, the manufacturer, and encoding area for 2D Serialization Barcode, Serial Number, Expiry, and Lot information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.